113 related articles for article (PubMed ID: 6205671)
1. Presence of alpha-1-antitrypsin in pancreatic carcinoma. Report of four cases in association with hepatic storage of the protease inhibitor.
Callea F; Goddeeris P; Mukunda RB; Geboes K; Bekaert J; Desmet VJ
Appl Pathol; 1983; 1(5):290-300. PubMed ID: 6205671
[TBL] [Abstract][Full Text] [Related]
2. Expression of the ets-1 proto-oncogene in human pancreatic carcinoma.
Ito T; Nakayama T; Ito M; Naito S; Kanematsu T; Sekine I
Mod Pathol; 1998 Feb; 11(2):209-15. PubMed ID: 9504693
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous alpha-1-antitrypsin accumulation in liver and pancreas.
Callea F; Fevery J; Desmet VJ
Hum Pathol; 1984 Mar; 15(3):293-5. PubMed ID: 6321324
[TBL] [Abstract][Full Text] [Related]
4. Alpha-antitrypsin deposition in primary hepatic carcinomas.
Palmer PE; Wolfe HJ
Arch Pathol Lab Med; 1976 May; 100(5):232-6. PubMed ID: 57764
[TBL] [Abstract][Full Text] [Related]
5. Expression of the bcl-2 gene and its significance in human pancreatic carcinoma.
Sun CY; Wang BL; Hu CQ; Peng RY; Gao YB; Gu QY; Wang DW
Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):306-8. PubMed ID: 14612291
[TBL] [Abstract][Full Text] [Related]
6. Relationship between expressions of E-cadherin and alpha-catenin and biological behaviors of human pancreatic cancer.
Li YJ; Meng YX; Ji XR
Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):471-7. PubMed ID: 14599963
[TBL] [Abstract][Full Text] [Related]
7. Expression of the MMP-1 in human pancreatic carcinoma: relationship with prognostic factor.
Ito T; Ito M; Shiozawa J; Naito S; Kanematsu T; Sekine I
Mod Pathol; 1999 Jul; 12(7):669-74. PubMed ID: 10430270
[TBL] [Abstract][Full Text] [Related]
8. Immunocytochemical distribution of trypsinogen and pancreatic secretory trypsin inhibitor in normal and neoplastic tissues in man.
Marks WH; Ohlsson K; Polling A
Scand J Gastroenterol; 1984 Jul; 19(5):673-6. PubMed ID: 6382569
[TBL] [Abstract][Full Text] [Related]
9. E-cadherin and DAP kinase in pancreatic adenocarcinoma and corresponding lymph node metastases.
Dansranjavin T; Möbius C; Tannapfel A; Bartels M; Wittekind C; Hauss J; Witzigmann H
Oncol Rep; 2006 May; 15(5):1125-31. PubMed ID: 16596173
[TBL] [Abstract][Full Text] [Related]
10. Expression of intermediate filaments in normal and neoplastic exocrine pancreas.
Santini D; Ceccarelli C; Martinelli GN; Pasquinelli G; Leone O; Marrano D; Mancini AM
Zentralbl Pathol; 1994 Aug; 140(3):247-58. PubMed ID: 7524653
[TBL] [Abstract][Full Text] [Related]
11. [Liver changes suggesting alpha-1-antitrypsin deficiency (a neglected disease)].
Bartók I; Korányi G; Bartók K; Nádor K; Hegedüs C
Orv Hetil; 1989 Sep; 130(36):1911-6, 1919. PubMed ID: 2674844
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of extracellular matrix proteins and adhesion molecules in pancreatic carcinoma.
Linder S; Castaños-Velez E; von Rosen A; Biberfeld P
Hepatogastroenterology; 2001; 48(41):1321-7. PubMed ID: 11677955
[TBL] [Abstract][Full Text] [Related]
13. p27 Kip1 expression is reduced in pancreatic carcinoma but has limited prognostic value.
Feakins RM; Ghaffar AH
Hum Pathol; 2003 Apr; 34(4):385-90. PubMed ID: 12733121
[TBL] [Abstract][Full Text] [Related]
14. [Alpha-1-antitrypsin deficiency and liver diseases].
Bartók K; Korányi G; Bartók K; Nádor K; Hegedũs C
Morphol Igazsagugyi Orv Sz; 1989 Oct; 29(4):249-54. PubMed ID: 2594021
[TBL] [Abstract][Full Text] [Related]
15. Alpha-1-antitrypsin (AAT) and its stimulation in the liver of PiMZ phenotype individuals. A "recruitment-secretory block" ("R-SB") phenomenon.
Callea F; Fevery J; Massi G; Lievens C; de Groote J; Desmet VJ
Liver; 1984 Oct; 4(5):325-37. PubMed ID: 6334213
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor-alpha expression in pancreatic ductal adenocarcinoma: association with clinicopathological parameters, tumor proliferative capacity, and patients' survival.
Giaginis C; Katsamangou E; Tsourouflis G; Zizi-Serbetzoglou D; Kouraklis G; Theocharis S
Med Sci Monit; 2009 May; 15(5):BR148-56. PubMed ID: 19396032
[TBL] [Abstract][Full Text] [Related]
17. Variant of intraductal carcinoma (with scant mucin production) is of main pancreatic duct origin: a clinicopathological study of four patients.
Suda K; Hirai S; Matsumoto Y; Mogaki M; Oyama T; Mitsui T; Fujibayashi M; Kumazawa K; Kajiwara T
Am J Gastroenterol; 1996 Apr; 91(4):798-800. PubMed ID: 8677955
[TBL] [Abstract][Full Text] [Related]
18. Diverse responses between human pancreatic cancer cell lines to native alpha 1-antitrypsin and its C-terminal fragment.
Zelvyte I; Ohlsson B; Axelson J; Janciauskiene S
Anticancer Res; 2003; 23(3B):2267-73. PubMed ID: 12894502
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of alpha 1-antitrypsin in hepatomas.
Reintoft I; Hägerstrand I
Arch Pathol Lab Med; 1979 Sep; 103(10):495-8. PubMed ID: 223516
[TBL] [Abstract][Full Text] [Related]
20. Ets-2 overexpression contributes to progression of pancreatic adenocarcinoma.
Ito Y; Miyoshi E; Takeda T; Sakon M; Ihara S; Tsujimoto M; Matsuura N
Oncol Rep; 2002; 9(4):853-7. PubMed ID: 12066221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
